Exclusive: US upends global supply program for malaria and HIV amid warnings of gaps - reuters.com
Exclusive: US upends global supply program for malaria and HIV amid warnings of gaps reuters.com
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxQeDFOU2Qwa3JoUDcxS2d0TDdCc0xKWTRVdkFoR3JTSEJ5ejBjdmRGVkllSjV5YWlfS1lXYnRQSHp1ajZPQ3RWZlp4UW9wU1podDl1RUVxb2NGeWRqeGdjZkdXbmNOZHQ4UVRxTnBIUlh5QUJxMjdSYURXZFZGWGNEb0h0d1EwODZkYUJHUzg0SXJoSU1rLWdMQjBvZ0pWYVdVNkp2TW9VX2twTFhQbk5mMk1qZklGV3dtZ0lOb3FyWm9aekxrTFhTMUpEN3ZfYnM?oc=5" target="_blank">Exclusive: US upends global supply program for malaria and HIV amid warnings of gaps</a> <font color="#6f6f6f">reuters.com</font>
The U.S. is changing its method of delivering medical supplies for diseases such as HIV and malaria to lower-income countries, risking disruption of life-saving services.
The U.S. is reshaping how it delivers life-saving medical supplies to poorer nations, a shift that officials and aid sources warn could disrupt treatment for millions battling HIV and malaria.
The U.S. is altering its approach to delivering medical supplies for diseases like HIV and malaria to lower-income countries, potentially disrupting life-saving services.
The U.S. is altering its approach to delivering medical supplies for diseases like HIV and malaria to lower-income countries, potentially disrupting life-saving services.
The U.S. is changing its method of delivering medical supplies for diseases such as HIV and malaria to lower-income countries, risking disruption of life-saving services.
The U.S. is altering its approach to delivering medical supplies for diseases like HIV and malaria to lower-income countries, potentially disrupting life-saving services.
The U.S. is altering its approach to delivering medical supplies for diseases like HIV and malaria to lower-income countries, potentially disrupting life-saving services.
Similar Stories
Related coverage based on topic and tags
US FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMTrump's frustrations drove order limiting child vaccinations, but MAHA wants more - Reuters
Trump's frustrations drove order limiting child vaccinations, but MAHA wants more Reuters
August 24, 2026 at 05:45 PMUS health department seeks public feedback on vaccine guidelines after Trump order - Reuters
US health department seeks public feedback on vaccine guidelines after Trump order Reuters
August 21, 2026 at 06:59 PMUS refiners face historic stress test as global crisis looms - Reuters
US refiners face historic stress test as global crisis looms Reuters
August 24, 2026 at 06:00 AMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AM| Reuters - Reuters
| Reuters Reuters
August 27, 2026 at 01:06 AM